Hussain Abbas — SEC Form 4 filings
SEC reporting owner CIK 1821956. 10 Form 4 filings on record with FilingPulse; latest filed 2026-05-08.
Transaction summary — filings shown
Covers all 10 filings on record, filed 2024-02-20 to 2026-05-08. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 3 legs across 3 filings — 6,498 shares, $287,598 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 22.
- Largest priced transaction: sale of 5,682 shares @ $46.63 ($264,952) in Moderna, Inc., filed 2026-05-04.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Moderna, Inc. (MRNA) | Director | 7 | — | 3 legs · 6,498 sh · $287,598 | 12 |
| Mallinckrodt plc | Director | 3 | — | — | 10 |
Form 4 filings — Hussain Abbas
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-05-08 | 4 | Moderna, Inc. (MRNA) | Grant/award (A): 8,371 (derivative) @ $0 | EDGAR |
| 2026-05-04 | 4 | Moderna, Inc. (MRNA) | Option exercise (M): 16,233 · Sale (S): 5,682 @ $46.63 · Option exercise (M): 16,233 (derivative) @ $0 | EDGAR |
| 2025-12-11 | 4 | Moderna, Inc. (MRNA) | Sale (S): 504 @ $27.60 | EDGAR |
| 2025-10-06 | 4 | Moderna, Inc. (MRNA) | Option exercise (M): 1,439 · Option exercise (M): 1,439 (derivative) @ $0 | EDGAR |
| 2025-08-04 | 4 | Mallinckrodt plc | Option exercise (M): 12,036 · Tax withholding (F): 3,433 · Grant/award (A): 16,414 (derivative) @ $0 · Disposition to issuer (D): 9,850 (derivative) · Option exercise (M): 12,036 (derivative) @ $0 | EDGAR |
| 2025-06-12 | 4 | Moderna, Inc. (MRNA) | Sale (S): 312 @ $28 | EDGAR |
| 2025-05-01 | 4 | Moderna, Inc. (MRNA) | Option exercise (M): 892 · Option exercise (M): 892 (derivative) @ $0 · Grant/award (A): 16,233 (derivative) @ $0 | EDGAR |
| 2025-01-02 | 4 | Mallinckrodt plc | Option exercise (M): 1,504 · Tax withholding (F): 324 · Disposition to issuer (D): 1,231 (derivative) · Option exercise (M): 1,504 (derivative) @ $0 | EDGAR |
| 2024-10-04 | 4 | Moderna, Inc. (MRNA) | Grant/award (A): 8,093 (derivative) @ $0 · Grant/award (A): 5,100 (derivative) @ $0 · Grant/award (A): 1,439 (derivative) @ $0 · Grant/award (A): 892 (derivative) @ $0 | EDGAR |
| 2024-02-20 | 4 | Mallinckrodt plc | Grant/award (A): 8,207 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1821956 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →